PATHOPHYSIOLOGY AND MANAGEMENT OF SEVERE HYPERCALCEMIA

被引:33
作者
NUSSBAUM, SR [1 ]
机构
[1] HARVARD UNIV,SCH MED,BOSTON,MA 02115
关键词
D O I
10.1016/S0889-8529(18)30170-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:343 / 362
页数:20
相关论文
共 94 条
[31]   A COMPARISON OF LOW VERSUS HIGH-DOSE PAMIDRONATE IN CANCER-ASSOCIATED HYPERCALCEMIA [J].
GALLACHER, SJ ;
RALSTON, SH ;
FRASER, WD ;
DRYBURGH, FJ ;
COWAN, RA ;
LOGUE, FC ;
BOYLE, IT .
BONE AND MINERAL, 1991, 15 (03) :249-256
[32]   INORGANIC PHOSPHATE TREATMENT OF HYPERCALCEMIA OF DIVERSE ETIOLOGIES [J].
GOLDSMITH, RS ;
INGBAR, SH .
NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (01) :1-+
[33]   COMPARATIVE-STUDY OF PAMIDRONATE DISODIUM AND ETIDRONATE DISODIUM IN THE TREATMENT OF CANCER-RELATED HYPERCALCEMIA [J].
GUCALP, R ;
RITCH, P ;
WIERNIK, PH ;
SARMA, PR ;
KELLER, A ;
RICHMAN, SP ;
TAUER, K ;
NEIDHART, J ;
MALLETTE, LE ;
SIEGEL, R ;
VANDEPOL, CJ .
JOURNAL OF CLINICAL ONCOLOGY, 1992, 10 (01) :134-142
[34]  
GURNEY H, 1989, LANCET, V2, P241
[35]   PARATHYROID-HORMONE-RELATED PROTEIN IN TUMORS ASSOCIATED WITH HYPERCALCEMIA [J].
HEATH, DA ;
SENIOR, PV ;
VARLEY, JM ;
BECK, F .
LANCET, 1990, 335 (8681) :66-69
[36]  
HEBERT LEE A., 1966, J CLIN INVEST, V45, P1886, DOI 10.1172/JCI105493
[37]   SIMILARITY OF SYNTHETIC PEPTIDE FROM HUMAN-TUMOR TO PARATHYROID-HORMONE INVIVO AND INVITRO [J].
HORIUCHI, N ;
CAULFIELD, MP ;
FISHER, JE ;
GOLDMAN, ME ;
MCKEE, RL ;
REAGAN, JE ;
LEVY, JJ ;
NUTT, RF ;
RODAN, SB ;
SCHOFIELD, TL ;
CLEMENS, TL ;
ROSENBLATT, M .
SCIENCE, 1987, 238 (4833) :1566-1568
[38]  
HOSKING DJ, 1981, Q J MED, V50, P473
[39]  
HOSKING DJ, 1984, Q J MED, V53, P359
[40]   EGF RECEPTOR ANTISERUM INHIBITS BONE RESORBING ACTIVITY PRODUCED BY A RAT LEYDIG-CELL TUMOR ASSOCIATED WITH THE HUMORAL HYPERCALCEMIA OF MALIGNANCY [J].
IBBOTSON, KJ ;
DSOUZA, SM ;
SMITH, DD ;
CARPENTER, G ;
MUNDY, GR .
ENDOCRINOLOGY, 1985, 116 (01) :469-471